Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Inventory Average (2021 - 2026)

Neuroone Medical Technologies filings provide 6 years of Inventory Average readings, the most recent being $1.4 million for Q1 2026.

  • On a quarterly basis, Inventory Average rose 53.59% to $1.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.4 million, a 53.59% increase, with the full-year FY2025 number at $1.6 million, up 19.21% from a year prior.
  • Inventory Average hit $1.4 million in Q1 2026 for Neuroone Medical Technologies, down from $1.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $1.7 million in Q4 2023 to a low of $225509.0 in Q1 2022.
  • Median Inventory Average over the past 5 years was $1.3 million (2024), compared with a mean of $1.1 million.
  • Biggest five-year swings in Inventory Average: surged 670.14% in 2022 and later tumbled 46.25% in 2024.
  • Neuroone Medical Technologies' Inventory Average stood at $804046.0 in 2022, then surged by 107.41% to $1.7 million in 2023, then tumbled by 46.25% to $896353.0 in 2024, then surged by 80.7% to $1.6 million in 2025, then decreased by 11.12% to $1.4 million in 2026.
  • The last three reported values for Inventory Average were $1.4 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025) per Business Quant data.